Zimmer Biomet Holdings (ZBH) closed at $107.32 on November 10, 2026, down 0.9% from the previous close, on volume of 1,694,529 shares (30-day average 2,191,242).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Strip Strangle | 20-Nov-2690[0.75x] P : 100 C | 1,750 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Zimmer Biomet Holdings (ZBH)
TipRanks (Mon, 9-Nov 9:30 AM ET)
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
PRNewswire (Mon, 9-Nov 7:30 AM ET)
TipRanks (Mon, 9-Nov 4:31 AM ET)
Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focus
Seeking Alpha News (Sun, 8-Nov 9:05 AM ET)
Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
PRNewswire (Fri, 6-Nov 7:30 AM ET)
Zimmer Biomet (ZBH) raises 2026 outlook as Q3 constant-currency sales growth reaches 3.7%
Market Chameleon (Wed, 4-Nov 4:05 AM ET)
Zimmer Biomet Announces Third Quarter 2026 Financial Results
PRNewswire (Wed, 4-Nov 6:30 AM ET)
Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026
PRNewswire (Thu, 29-Oct 7:30 AM ET)
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
PRNewswire (Tue, 13-Oct 7:31 AM ET)
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
PRNewswire (Tue, 6-Oct 7:30 AM ET)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The company has assembled a wide array of robotic platforms, and it spun out its dental and spine businesses in 2022.
Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.
As of November 10, 2026, ZBH stock price declined to $107.32 with 1,694,529 million shares trading.
ZBH has a beta of -0.01, meaning it tends to be less sensitive to market movements. ZBH has a correlation of 0.00 to the broad based SPY ETF.
ZBH has a market cap of $21.00 billion. This is considered a Large Cap stock.
Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $1.90 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.02.
In the last 3 years, ZBH traded as high as $133.90 and as low as $79.12.
The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, VB, MOAT, IVV.
ZBH has outperformed the market in the last year with a price return of +22.4% while the SPY ETF gained +12.9%. ZBH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.4% and +10.1%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
ZBH support price is $106.16 and resistance is $110.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH shares will trade within this expected range on the day.
